======= NIT2 ======= == Gene Information == * **Official Symbol**: NIT2 * **Official Name**: nitrilase family member 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56954|56954]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQR4|Q9NQR4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NIT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NIT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616769|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Has a omega-amidase activity. The role of omega-amidase is to remove potentially toxic intermediates by converting alpha- ketoglutaramate and alpha-ketosuccinamate to biologically useful alpha-ketoglutarate and oxaloacetate, respectively. Overexpression decreases the colony-forming capacity of cultured cells by arresting cells in the G2 phase of the cell cycle. {ECO:0000269|PubMed:17488281, ECO:0000269|PubMed:19595734}. |CN hydrolase| |omega-amidase activity| |asparagine metabolic process| |oxaloacetate metabolic process| |glutamine metabolic process| |aspartate family amino acid metabolic process| |tertiary granule lumen| |specific granule lumen| |glutamine family amino acid metabolic process| |dicarboxylic acid metabolic process| |alpha-amino acid metabolic process| |cellular amino acid metabolic process| |neutrophil degranulation| |centrosome| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |monocarboxylic acid metabolic process| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |cellular amide metabolic process| |exocytosis| |carboxylic acid metabolic process| |leukocyte activation| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |export from cell| |cell activation| |immune effector process| |secretion| |small molecule metabolic process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.77| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|7.77| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.47| |[[:human genes:h:hif1a|HIF1A]]|0.419| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16561 * **Expression level (log2 read counts)**: 5.87 {{:chemogenomics:nalm6 dist.png?nolink |}}